Tag: Novo Nordisk

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Novo Nordisk

Weight-loss, diabetes drugs linked to vision problems in small study | Fox News

Added to Collection on: 2025-02-14 22:22:38

Tags for this article:

Peptide hormones
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Semaglutide
Anterior ischemic optic neuropathy
Anti-obesity medication
Glucagon-like peptide-1
Non-arteritic anterior ischemic optic neuropathy
Novo Nordisk
Optic neuropathy
Diabetes
Type 2 diabetes

Click the tags to see associated articles and topics

View Article Details
Key Trends Shaping the Future Antiobesity Market From - openPR.com

Added to Collection on: 2025-02-17 08:51:41

Tags for this article:

NIFTY 50
Bariatrics
Body shape
Nutrition
Obesity
Eli Lilly and Company
Pharmaceutical industry in China
Roche
Sun Pharma
Novo Nordisk
Anti-obesity medication
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
Hidden Ties Behind Ozempic Maker's Billion-Dollar Empire: BlackRock and Vanguard's ...

Added to Collection on: 2025-02-17 19:29:29

Tags for this article:

Exchange-traded funds
Novo Nordisk
Goldman Sachs
BlackRock
GQG Partners
Semaglutide
Novo
Nordisk
The Vanguard Group

Click the tags to see associated articles and topics

View Article Details
Eli Lilly comes for knockoff weight loss drugs in new ad campaign - Quartz

Added to Collection on: 2025-03-01 14:27:25

Tags for this article:

Peptide hormones
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Hims & Hers Health
Telemedicine
Anti-obesity medication
Semaglutide
Eli Lilly and Company
Ro
Tirzepatide
Compounding
Novo Nordisk
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk's obesity drug CagriSema disappoints again - European Biotechnology

Added to Collection on: 2025-03-10 20:23:08

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Peptide hormones
Cagrilintide/semaglutide
Semaglutide
Anti-obesity medication
Tirzepatide
Cagrilintide
Glucagon-like peptide-1
Novo Nordisk
Obesity
Amylin
Novo Nordisk A/S

Click the tags to see associated articles and topics

View Article Details
Exploring the Wide World of GLP-1s | AMCP Annual 2025

Added to Collection on: 2025-04-03 23:07:12

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Peptide hormones
Semaglutide
Tirzepatide
Glucagon-like peptide-1
Liraglutide
Exenatide
Sleep apnea
Obstructive sleep apnea
Novo Nordisk
Eli Lilly and Company
Kristen Patti

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk readies to bring weight-loss drug Wegovy to India - The Economic Times

Added to Collection on: 2025-04-06 19:17:17

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Peptide hormones
In Denmark
In science
Semaglutide
Novo Nordisk
Anti-obesity medication
Tirzepatide
Eli Lilly and Company
Diabetes
Lotte Bjerre Knudsen
Eli Lilly
India

Click the tags to see associated articles and topics

View Article Details
Medicare Will Not Cover GLP-1 Drugs for Weight Loss | TIME

Added to Collection on: 2025-04-07 18:55:33

Tags for this article:

Healthcare reform in the United States
GLP-1 receptor agonists
Peptide hormones
PEPTIDE THERAPEUTICS
Federal assistance in the United States
Semaglutide
Anti-obesity medication
Novo Nordisk
Medicaid
Medicare
Centers for Medicare & Medicaid Services
Tirzepatide
the centers for medicare and medicaid services

Click the tags to see associated articles and topics

View Article Details
Biden Plan To Expand Obesity Drug Coverage Is Rejected | Health | news-expressky.com

Added to Collection on: 2025-04-07 15:49:25

Tags for this article:

Healthcare reform in the United States
Federal assistance in the United States
Presidency of Lyndon B. Johnson
Child poverty
Medicaid
Anti-obesity medication
Semaglutide
Medicare
Centers for Medicare & Medicaid Services
Obesity
Novo Nordisk
Medicare Part D coverage gap

Click the tags to see associated articles and topics

View Article Details
Patients, European And Indian Drug Companies Will Suffer Most From Trump Tariffs On ...

Added to Collection on: 2025-04-09 16:38:55

Tags for this article:

Research and development in the United States
Healthcare in India
Pharmaceuticals policy
Pharmaceutical industry
Novartis
Pharmaceutical industry in India
Pharmaceutical industry in China
Eli Lilly and Company
Bayer
Novo Nordisk
European Federation of Pharmaceutical Industries and Associations
Sanofi
United States
US Dollar
Donald Trump

Click the tags to see associated articles and topics

View Article Details